Pathologic Response and Tumor-Infiltrating Lymphocytes during Chemoradiotherapy: Promising Predictive and Prognostic Markers for Chemoradiotherapy Response and Outcome in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

被引:0
|
作者
Qian, D. [1 ]
Wang, Y. [2 ]
Pang, Q. [3 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent Therapy,Dept Radiat Oncol, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Radiotherapy, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Radiotherapy, Tianjin, Peoples R China
关键词
D O I
10.1016/j.ijrobp.2018.07.540
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SU_10_2091
引用
收藏
页码:E39 / E40
页数:2
相关论文
共 50 条
  • [41] Locally advanced breast cancer: Tumor-infiltrating lymphocytes as a predictive factor of response to neoadjuvant chemotherapy
    Russo, Leonardo
    Maltese, Anggela
    Betancourt, Luis
    Romero, Gabriel
    Cialoni, Daniela
    De la Fuente, Liliana
    Gutierrez, Marianna
    Ruiz, Angela
    Aguero, Emperatriz
    Hernandez, Silvia
    EJSO, 2019, 45 (06): : 963 - 968
  • [42] Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Park, Sehhoon
    Oh, Dongryul
    Choi, Yoon-La
    Chi, Sang Ah
    Kim, Kyunga
    Ahn, Myung-Ju
    Sun, Jong-Mu
    CANCER, 2022, 128 (11) : 2148 - 2158
  • [43] Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma
    Kermani, Ali Taghizadeh
    Ghanbarzadeh, Raha
    Mashhad, Mona Joudi
    Javadinia, Seyed Alireza
    Torghabeh, Ali Emadi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Genomic characteristics in neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    He, Wenwu
    Leng, Xuefeng
    Wang, Kangning
    Mao, Tiaoqin
    Peng, Lin
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1105 - 1112
  • [45] A retrospective study of postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Yeh, Hui-Ling
    Hsu, Chung-Ping
    Lin, Jin-Ching
    Jan, Jian-Sheng
    Lin, Jai-Fu
    Chang, Chen-Fa
    FORMOSAN JOURNAL OF SURGERY, 2012, 45 (06) : 172 - 177
  • [46] Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
    Wieder, HA
    Brücher, BLDM
    Zimmermann, F
    Becker, K
    Lordick, F
    Beer, A
    Schwaiger, M
    Fink, U
    Siewert, JR
    Stein, HJ
    Weber, WA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 900 - 908
  • [47] Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
    Chih-Yi Chen
    Chia-Chin Li
    Chun-Ru Chien
    World Journal of Surgical Oncology, 16
  • [48] Endoscopic Traversability in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy: Is it an Important Prognostic Factor?
    Moon, Hee Seok
    Jeong, Hyun Yong
    Sung, Jaekyu
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB212 - AB212
  • [49] Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy: Is it an important prognostic factor?
    Hyung, Kang Sun
    Kyu, Sung Jae
    Yong, Jeong Hyun
    Seok, Moon Hee
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma
    Xu, Qiaoshi
    Wang, Chong
    Yuan, Xiaohong
    Feng, Zhien
    Han, Zhengxue
    TRANSLATIONAL ONCOLOGY, 2017, 10 (01): : 10 - 16